Obesity is a highly prevalent public health concern, attributed to multifactorial causes and
limited in treatment options. Several comorbidities are closely associated with obesity such …

Obesity contributes to reduced life expectancy because of its link with type 2 diabetes and
cardiovascular disease. Yet, targeting this poorly diagnosed, ill-defined, and …

Background Visceral and ectopic fat are key drivers of adverse cardiometabolic outcomes in
obesity. We aimed to evaluate the effects of injectable liraglutide 3· 0 mg daily on body fat …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide and obesity is a
major risk factor that increases the morbidity and mortality of CVDs. Lifestyle modifications …

Proinflammatory biomarkers have been increasingly used in epidemiologic and intervention
studies over the past decades to evaluate and identify an association of systemic …

The obesity epidemic, mainly due to lifestyle changes in recent decades, leads to serious
comorbidities that reduce life expectancy. This situation is affecting the health policies of …

The escalating prevalence of individuals becoming overweight and obese is a rapidly rising
global health problem, placing an enormous burden on health and economic systems …

Aberrant circulating omentin-1, which is an anti-inflammatory and pro-apoptotic adipokine,
has been reported in various solid tumors. Therefore, we investigated whether circulating …

No study has examined myocardial work in subjects with cancer therapy-related cardiac
dysfunction (CTRCD). Myocardial work, as a new ultrasonic indicator, reflects the …

Abstract Purpose of Review To summarize research from the last 5 years on the effects of
weight loss treatments, including lifestyle changes, anti-obesity medications, and bariatric …